SURGE Therapeutics
PrivateLast Round
Series B
Jul 19, 2023
Total Funding Raised
$58M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SURGE Therapeutics is a biotechnology company that specializes in a proprietary technology-based platform for delivering localized immunotherapy through an injectable biodegradable hydrogel designed to enhance cancer treatment during surgical tumor resection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SURGE Therapeutics Comparables
Compare SURGE Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lithea AB | 75% | |
| Attivare Therapeutics | 73% | |
| Gordian Pharma Ltd. | 72% |
SURGE Therapeutics Funding Rounds
Historical fundraising activity
SURGE Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Camford Capital | Series B, Series A |
| Bioluminescence Ventures | Series B |
| Khosla Ventures | Series A, Series B |
| Intuitive Ventures | Series B, Series A |
| Cancer Research Institute | Series A, Series B |
| 8VC | Series A, Series B |
| Camford Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 40% MoM.
- Jul 19, 2023
$32M round led by Bioluminescence Ventures.
SURGE Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SURGE Therapeutics's valuation, stock price, and market status.
Is SURGE Therapeutics a public or private company?
SURGE Therapeutics is a private company.
What is the current stock price of SURGE Therapeutics?
SURGE Therapeutics is a private company, so its shares have no public market price. Caplight tracks SURGE Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SURGE Therapeutics worth (valuation)?
Valuation information for SURGE Therapeutics is not publicly available.
Can I buy SURGE Therapeutics stock?
SURGE Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SURGE Therapeutics's last funding round?
SURGE Therapeutics's most recent funding round was Series B on July 19, 2023.
Who are the main investors in SURGE Therapeutics?
Key investors in SURGE Therapeutics include Camford Capital, Bioluminescence Ventures, Camford Capital.
Will SURGE Therapeutics IPO soon?
No public IPO plans have been announced for SURGE Therapeutics.
How can I track SURGE Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in SURGE Therapeutics's shares on secondary markets.